chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac failure acute, Cardiac failure congestive, Cerebrovascular accident, Confusional state
Clinical narrative: Patient with COVID vaccinations who admitted with incidental positive COVID test.  Provider d/c note:  ""73 YO M with hx afib, HTN, CKD, hx SAH, dementia, who was admitted for acute on chronic right sided weakness. He had distant history of stroke with R sided weakness, but was more weak than usual. Admitted for stroke workup. He was also found to have incidental COVID-19 infection.  He was found on MRI to have acute to subacute infarct at the left corona radiata extending to the left basal ganglia.  CT angiogram showed multilevel stenosis without large vessel occlusion.  Neurology was consulted.  He was restarted on Eliquis, aspirin and statin.   His course was complicated by acute on chronic CHF and acute kidney injury.  Cardiology and Nephrology were consulted early in his hospital course for assistance managing those issues with improvement.  He also developed prolonged episode of confusion and agitation thought to be due to delirium in setting of advanced dementia.  Over time and with assistance of Seroquel this also improved significantly.  Discharge was delayed primarily due to agitation and mental status changes.  As these issues resolved he was thought to be a candidate for transition to SNF with therapy.  Discharged in good condition."
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Delirium, Dementia, Hemiparesis, Magnetic resonance imaging head abnormal, Mental status changes
Clinical narrative: Patient with COVID vaccinations who admitted with incidental positive COVID test.  Provider d/c note:  ""73 YO M with hx afib, HTN, CKD, hx SAH, dementia, who was admitted for acute on chronic right sided weakness. He had distant history of stroke with R sided weakness, but was more weak than usual. Admitted for stroke workup. He was also found to have incidental COVID-19 infection.  He was found on MRI to have acute to subacute infarct at the left corona radiata extending to the left basal ganglia.  CT angiogram showed multilevel stenosis without large vessel occlusion.  Neurology was consulted.  He was restarted on Eliquis, aspirin and statin.   His course was complicated by acute on chronic CHF and acute kidney injury.  Cardiology and Nephrology were consulted early in his hospital course for assistance managing those issues with improvement.  He also developed prolonged episode of confusion and agitation thought to be due to delirium in setting of advanced dementia.  Over time and with assistance of Seroquel this also improved significantly.  Discharge was delayed primarily due to agitation and mental status changes.  As these issues resolved he was thought to be a candidate for transition to SNF with therapy.  Discharged in good condition."
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Stenosis
Clinical narrative: Patient with COVID vaccinations who admitted with incidental positive COVID test.  Provider d/c note:  ""73 YO M with hx afib, HTN, CKD, hx SAH, dementia, who was admitted for acute on chronic right sided weakness. He had distant history of stroke with R sided weakness, but was more weak than usual. Admitted for stroke workup. He was also found to have incidental COVID-19 infection.  He was found on MRI to have acute to subacute infarct at the left corona radiata extending to the left basal ganglia.  CT angiogram showed multilevel stenosis without large vessel occlusion.  Neurology was consulted.  He was restarted on Eliquis, aspirin and statin.   His course was complicated by acute on chronic CHF and acute kidney injury.  Cardiology and Nephrology were consulted early in his hospital course for assistance managing those issues with improvement.  He also developed prolonged episode of confusion and agitation thought to be due to delirium in setting of advanced dementia.  Over time and with assistance of Seroquel this also improved significantly.  Discharge was delayed primarily due to agitation and mental status changes.  As these issues resolved he was thought to be a candidate for transition to SNF with therapy.  Discharged in good condition."
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: 8/19/2022 presented to ER with cough and increased weakness per family since patient has dementia. Tested Covid + 8/19/2022.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pruritus, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: Noticed late on 9/1/2022, her right arm (injection site) was swollen, itchy, hot, bruised and had a welt.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Noticed late on 9/1/2022, her right arm (injection site) was swollen, itchy, hot, bruised and had a welt.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, Cough, Fatigue, Laryngitis
Clinical narrative: I got laryngitis then a little bit of a cough. Then fatigue and fever set in that lasted a couple of days. The cough was on and off. The fever subsided and the cough is still here and I'm getting my energy back but not completely over it. The doctors thought it was an asthmatic bronchitis. I did not test positive for COVID-19.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: I got laryngitis then a little bit of a cough. Then fatigue and fever set in that lasted a couple of days. The cough was on and off. The fever subsided and the cough is still here and I'm getting my energy back but not completely over it. The doctors thought it was an asthmatic bronchitis. I did not test positive for COVID-19.
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angiogram pulmonary normal, Asthenia, COVID-19, Cough, Dyspnoea
Clinical narrative: Patient up to date on COVID vaccines who admitted with complications r/t COVID and COVID detected PCR.  Provider d/c note:  "94 F with PMH HLD, Anemia, HTN, OA, Mild Cognitive impairment with memory loss, Chronic Insomnia, Depression  who is presenting to the ED for evaluation of worsening weakness, cough, and SOB.   Patient is on chronic O2 nasal cannula at home.  Was found outpatient to be COVID positive and started on Paxlovid   Initial workup included a CTA that was negative for PE.  Patient was found to be COVID positive.  Patient was started on Decadron as well as remdesivir and monitored overnight.  Patient maintained on her home O2 nasal cannula and her strength improved.  Patient was discharged home to resume Paxlovid therapy and follow-up with primary care provider for continued care."
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient up to date on COVID vaccines who admitted with complications r/t COVID and COVID detected PCR.  Provider d/c note:  "94 F with PMH HLD, Anemia, HTN, OA, Mild Cognitive impairment with memory loss, Chronic Insomnia, Depression  who is presenting to the ED for evaluation of worsening weakness, cough, and SOB.   Patient is on chronic O2 nasal cannula at home.  Was found outpatient to be COVID positive and started on Paxlovid   Initial workup included a CTA that was negative for PE.  Patient was found to be COVID positive.  Patient was started on Decadron as well as remdesivir and monitored overnight.  Patient maintained on her home O2 nasal cannula and her strength improved.  Patient was discharged home to resume Paxlovid therapy and follow-up with primary care provider for continued care."
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient on rehab unit for therapy and tested detected for COVID.  Asymptomatic.  Discharged home.
Age: 77.0
Sex: F
Vaccine: YF
Symptoms: Asthenia, Electromyogram, Guillain-Barre syndrome, Headache, Muscular weakness
Clinical narrative: Patient reports on had headache the night after getting vaccine and the next day went to get up and felt weak her knees buckled.  She reports seeing a doctor and was referred to a neurologist. The neurologist did an  EMG  on 8/17/2022 and she was diagnosed with Guillian Barre . She reports some improvement on 9/2 still has leg weakness.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Cardiac amyloidosis, Cardiogenic shock, Central venous catheterisation, Condition aggravated
Clinical narrative: Admission Date: 8/26/2022 Discharge Date: 08/31/2022 Presenting Problem: Cardiogenic shock (HCC)  HOSPITAL COURSE: Patient is an 84 year old male with PMH of chronic diastolic heart failure, cardiac amyloid TTR, persistent Afib on ASA only 2/2 hx rectal bleeding, CAD s/p CABG and LAA excision 3/2021, pulmonary sarcoidosis, hypertension, hyperlipidemia, orthostatic hypotension, OSA on CPAP, CKD 3b, thoracic aortic aneurysm, and venous insufficiency.    He was hospitalized July 2022 with SOB and LE edema, ultimately diagnosed with cardiac amyloid based on CMR and PYP scan. He does have hx of Afib but has LAA ligation and with hx of GIB, he was not discharged on DOAC. He was discharged with torsemide, BB, spiro and since been started on tafamidis in the clinic.    Patient saw Dr. as follow up on 8/25 and reported feeling miserable for the last month; DOE, SOB, lightheaded, dizzy. He was scheduled for urgent RHC to assess hemodynamics. RHC on 8/26 showed low filling pressures but cardiogenic shock (RA 8, PA 50/14/24, W 14, FCI 1.2, wt 94.7 kg) and he was subsequently admitted for optimization. He was started on milrinone 0.2. He remained in Afib with elevated HRs, but given exteremly low FCI, his BB dose was reduced and then discontinued. Typically digoxin is contraindicated in patients with amyloid, but discussed with AHF providers, some clinical success with low dose digoxin so he was started on digoxin. Also, given Afib and amyloidosis, it was recommended that he start OAC; he was started on low dose eliquis 2.5mg bid. If rectal bleeding recurs, can discuss stopping OAC again. Prior to discharge, RUE PICC line was placed for home milrinone.  Palliative care saw patient this admission, patient aware of condition and prognosis long term, and would like Hospice to call him next week to set up an informational meeting once patient is home. Patient stable for discharge on IV milrinone at 0.2 mcg/kg/min on 8/31/22.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Dyspnoea exertional, Feeling abnormal, Heart rate increased
Clinical narrative: Admission Date: 8/26/2022 Discharge Date: 08/31/2022 Presenting Problem: Cardiogenic shock (HCC)  HOSPITAL COURSE: Patient is an 84 year old male with PMH of chronic diastolic heart failure, cardiac amyloid TTR, persistent Afib on ASA only 2/2 hx rectal bleeding, CAD s/p CABG and LAA excision 3/2021, pulmonary sarcoidosis, hypertension, hyperlipidemia, orthostatic hypotension, OSA on CPAP, CKD 3b, thoracic aortic aneurysm, and venous insufficiency.    He was hospitalized July 2022 with SOB and LE edema, ultimately diagnosed with cardiac amyloid based on CMR and PYP scan. He does have hx of Afib but has LAA ligation and with hx of GIB, he was not discharged on DOAC. He was discharged with torsemide, BB, spiro and since been started on tafamidis in the clinic.    Patient saw Dr. as follow up on 8/25 and reported feeling miserable for the last month; DOE, SOB, lightheaded, dizzy. He was scheduled for urgent RHC to assess hemodynamics. RHC on 8/26 showed low filling pressures but cardiogenic shock (RA 8, PA 50/14/24, W 14, FCI 1.2, wt 94.7 kg) and he was subsequently admitted for optimization. He was started on milrinone 0.2. He remained in Afib with elevated HRs, but given exteremly low FCI, his BB dose was reduced and then discontinued. Typically digoxin is contraindicated in patients with amyloid, but discussed with AHF providers, some clinical success with low dose digoxin so he was started on digoxin. Also, given Afib and amyloidosis, it was recommended that he start OAC; he was started on low dose eliquis 2.5mg bid. If rectal bleeding recurs, can discuss stopping OAC again. Prior to discharge, RUE PICC line was placed for home milrinone.  Palliative care saw patient this admission, patient aware of condition and prognosis long term, and would like Hospice to call him next week to set up an informational meeting once patient is home. Patient stable for discharge on IV milrinone at 0.2 mcg/kg/min on 8/31/22.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging heart, Oedema peripheral, Scan
Clinical narrative: Admission Date: 8/26/2022 Discharge Date: 08/31/2022 Presenting Problem: Cardiogenic shock (HCC)  HOSPITAL COURSE: Patient is an 84 year old male with PMH of chronic diastolic heart failure, cardiac amyloid TTR, persistent Afib on ASA only 2/2 hx rectal bleeding, CAD s/p CABG and LAA excision 3/2021, pulmonary sarcoidosis, hypertension, hyperlipidemia, orthostatic hypotension, OSA on CPAP, CKD 3b, thoracic aortic aneurysm, and venous insufficiency.    He was hospitalized July 2022 with SOB and LE edema, ultimately diagnosed with cardiac amyloid based on CMR and PYP scan. He does have hx of Afib but has LAA ligation and with hx of GIB, he was not discharged on DOAC. He was discharged with torsemide, BB, spiro and since been started on tafamidis in the clinic.    Patient saw Dr. as follow up on 8/25 and reported feeling miserable for the last month; DOE, SOB, lightheaded, dizzy. He was scheduled for urgent RHC to assess hemodynamics. RHC on 8/26 showed low filling pressures but cardiogenic shock (RA 8, PA 50/14/24, W 14, FCI 1.2, wt 94.7 kg) and he was subsequently admitted for optimization. He was started on milrinone 0.2. He remained in Afib with elevated HRs, but given exteremly low FCI, his BB dose was reduced and then discontinued. Typically digoxin is contraindicated in patients with amyloid, but discussed with AHF providers, some clinical success with low dose digoxin so he was started on digoxin. Also, given Afib and amyloidosis, it was recommended that he start OAC; he was started on low dose eliquis 2.5mg bid. If rectal bleeding recurs, can discuss stopping OAC again. Prior to discharge, RUE PICC line was placed for home milrinone.  Palliative care saw patient this admission, patient aware of condition and prognosis long term, and would like Hospice to call him next week to set up an informational meeting once patient is home. Patient stable for discharge on IV milrinone at 0.2 mcg/kg/min on 8/31/22.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: There is no adverse event - this is to report that an expired vaccine was given to a patient.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Cardiovascular examination, Chest pain, Electrocardiogram, X-ray
Clinical narrative: Right chest pain, he was transported to another hospital. Spent the night in hospital and released home on July 20 with a follow up with his pediatrician and a heart doctor.
Age: 42.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site cellulitis, Injection site erythema, Injection site infection, Injection site pain, Injection site swelling
Clinical narrative: Severe swelling, redness, pain around the injection site. Within 24 hours, swelling increased and redness started moving up left arm. A large bubble/blister appeared over injection site. Called office to report issue and they said to contact primary doctor as it appeared to be infected and none of the information the nurses were provided with for monkeypox side effects matched the redness/swelling, blister.  Was advised by doctor to go to the hospital.  Hospital stated the injection site was infected and put me on an antibiotic for cellulitis. Doctor stated it could have been caused by the nurse not sterilizing the injection site properly, the needle being contaminated, the bandage being contaminated,  the vaccine being contaminated as they?re being used for several people, etc.
Age: 42.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site vesicles
Clinical narrative: Severe swelling, redness, pain around the injection site. Within 24 hours, swelling increased and redness started moving up left arm. A large bubble/blister appeared over injection site. Called office to report issue and they said to contact primary doctor as it appeared to be infected and none of the information the nurses were provided with for monkeypox side effects matched the redness/swelling, blister.  Was advised by doctor to go to the hospital.  Hospital stated the injection site was infected and put me on an antibiotic for cellulitis. Doctor stated it could have been caused by the nurse not sterilizing the injection site properly, the needle being contaminated, the bandage being contaminated,  the vaccine being contaminated as they?re being used for several people, etc.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient on rehab unit for therapy and tested detected for COVID.  Mildly symptomatic, no hypoxia.  Provider d/c note:  "1. Patient had mildly symptomatic covid-19 but has been removed from isolation and is asymptomatic and afebrile at discharge."
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Dyspnoea, Fatigue, Headache
Clinical narrative: I contracted Covid19 which started with a headache and tiredness on day one, by day two sinus issues and widespread body aches along with the headache and tiredness. Day three brought severe and debilitating body aches and headaches, shortness of breath, severe cramps and violent diarrhea, nausea, and chest congestion. A fever no greater than 101.7 accompanied the symptoms for three days with the symptoms lessening each day after the 1st three. Called the doctor on a Monday morning and was prescribed Paxlovid. Treated the symptoms with OTC meds as needed, used only Tylenol for the fever, drank vitamin C supplement twice a day, and quarantined for 7 days. The Paxlovid started to make a difference halfway through the 2nd day of taking it. As of this statement, I have 1.5 days left of taking the medicine and although a continue to deal with mild headaches and my energy level is diminished the medicine has worked satisfactorily.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Nausea, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I contracted Covid19 which started with a headache and tiredness on day one, by day two sinus issues and widespread body aches along with the headache and tiredness. Day three brought severe and debilitating body aches and headaches, shortness of breath, severe cramps and violent diarrhea, nausea, and chest congestion. A fever no greater than 101.7 accompanied the symptoms for three days with the symptoms lessening each day after the 1st three. Called the doctor on a Monday morning and was prescribed Paxlovid. Treated the symptoms with OTC meds as needed, used only Tylenol for the fever, drank vitamin C supplement twice a day, and quarantined for 7 days. The Paxlovid started to make a difference halfway through the 2nd day of taking it. As of this statement, I have 1.5 days left of taking the medicine and although a continue to deal with mild headaches and my energy level is diminished the medicine has worked satisfactorily.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus disorder
Clinical narrative: I contracted Covid19 which started with a headache and tiredness on day one, by day two sinus issues and widespread body aches along with the headache and tiredness. Day three brought severe and debilitating body aches and headaches, shortness of breath, severe cramps and violent diarrhea, nausea, and chest congestion. A fever no greater than 101.7 accompanied the symptoms for three days with the symptoms lessening each day after the 1st three. Called the doctor on a Monday morning and was prescribed Paxlovid. Treated the symptoms with OTC meds as needed, used only Tylenol for the fever, drank vitamin C supplement twice a day, and quarantined for 7 days. The Paxlovid started to make a difference halfway through the 2nd day of taking it. As of this statement, I have 1.5 days left of taking the medicine and although a continue to deal with mild headaches and my energy level is diminished the medicine has worked satisfactorily.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None - this is for the reporting of an expired Vaccine given to a patient.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Agitation, Arrhythmia, COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C  Admission Date: 8/28/2022  PRESENTING PROBLEM: Acute on chronic respiratory failure with hypercapnia (HCC) [J96.22] Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.21, J96.22]   HOSPITAL COURSE: Patient is a 77-year-old male with a history of significant comorbid conditions including end-stage chronic obstructive pulmonary disease, systolic congestive heart failure, chronic kidney disease as well as chronic respiratory failure with hypoxia and hypercapnia.  Patient was admitted to the hospital on August 28, 2022 for acute on chronic respiratory failure with hypoxia and hypercarbia in the setting of COVID-19 infection complicated by chronic obstructive pulmonary disease and congestive heart failure.  Patient was also noted to have acute kidney injury superimposed on chronic kidney disease.  The patient was admitted to the intensive care unit for treatment of respiratory failure with BiPAP.  Patient's hospital course was complicated by agitation, delirium and cardiac arrhythmia.  The patient struggled with the use of BiPAP which seemed to make him more agitated.  With the patient's condition failed to improve, patient's family elected to transition patient into comfort and hospice care.  This decision was made August 31, 2022. Patient was placed into comfort care order set with family at bedside.  Patient expired peacefully today September 1, 2022 at 11:09 p.m..  Family was at bedside and present.  Message sent primary care provider for notification.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chronic kidney disease, Chronic obstructive pulmonary disease, Condition aggravated, Death
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C  Admission Date: 8/28/2022  PRESENTING PROBLEM: Acute on chronic respiratory failure with hypercapnia (HCC) [J96.22] Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.21, J96.22]   HOSPITAL COURSE: Patient is a 77-year-old male with a history of significant comorbid conditions including end-stage chronic obstructive pulmonary disease, systolic congestive heart failure, chronic kidney disease as well as chronic respiratory failure with hypoxia and hypercapnia.  Patient was admitted to the hospital on August 28, 2022 for acute on chronic respiratory failure with hypoxia and hypercarbia in the setting of COVID-19 infection complicated by chronic obstructive pulmonary disease and congestive heart failure.  Patient was also noted to have acute kidney injury superimposed on chronic kidney disease.  The patient was admitted to the intensive care unit for treatment of respiratory failure with BiPAP.  Patient's hospital course was complicated by agitation, delirium and cardiac arrhythmia.  The patient struggled with the use of BiPAP which seemed to make him more agitated.  With the patient's condition failed to improve, patient's family elected to transition patient into comfort and hospice care.  This decision was made August 31, 2022. Patient was placed into comfort care order set with family at bedside.  Patient expired peacefully today September 1, 2022 at 11:09 p.m..  Family was at bedside and present.  Message sent primary care provider for notification.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Delirium, General physical health deterioration, Intensive care, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C  Admission Date: 8/28/2022  PRESENTING PROBLEM: Acute on chronic respiratory failure with hypercapnia (HCC) [J96.22] Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.21, J96.22]   HOSPITAL COURSE: Patient is a 77-year-old male with a history of significant comorbid conditions including end-stage chronic obstructive pulmonary disease, systolic congestive heart failure, chronic kidney disease as well as chronic respiratory failure with hypoxia and hypercapnia.  Patient was admitted to the hospital on August 28, 2022 for acute on chronic respiratory failure with hypoxia and hypercarbia in the setting of COVID-19 infection complicated by chronic obstructive pulmonary disease and congestive heart failure.  Patient was also noted to have acute kidney injury superimposed on chronic kidney disease.  The patient was admitted to the intensive care unit for treatment of respiratory failure with BiPAP.  Patient's hospital course was complicated by agitation, delirium and cardiac arrhythmia.  The patient struggled with the use of BiPAP which seemed to make him more agitated.  With the patient's condition failed to improve, patient's family elected to transition patient into comfort and hospice care.  This decision was made August 31, 2022. Patient was placed into comfort care order set with family at bedside.  Patient expired peacefully today September 1, 2022 at 11:09 p.m..  Family was at bedside and present.  Message sent primary care provider for notification.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient with COVID Vaccinations who admitted with complications from COVID with COVID detected PCR.  Provider d/c note:  "Patient was admitted and started on remdesivir, dexamethasone along with serial breathing tx, brisk improvement in her symptoms. Patient able to quickly wean down to 2L O2 which patient uses at home, mainly when she sleeps. Patient was instructed to wear O2 continuously for the next few days-weeks, pt expressed understanding. Patient otherwise remained hemodynamically stable throughout the hospital stay. "
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Nasal congestion, Oropharyngeal pain, Pain
Clinical narrative: It was around 4 o'clock and got up and got up and was extremely tired and had fatigue with achiness and the next day I woke up stuffy with a little sore throat. I was not aware I had an exposure and I was waiting thinking I didn't need to test to early but decided to take a test anyway and it was positive with a COVID-19 home test. That was on a Friday that I tested positive and my daughter is a Physician assistant and she ordered the PAXLOVID for me and on Sunday I was still having symptoms and Monday I was feeling better. I tested again on Tuesday and I was negative.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: It was around 4 o'clock and got up and got up and was extremely tired and had fatigue with achiness and the next day I woke up stuffy with a little sore throat. I was not aware I had an exposure and I was waiting thinking I didn't need to test to early but decided to take a test anyway and it was positive with a COVID-19 home test. That was on a Friday that I tested positive and my daughter is a Physician assistant and she ordered the PAXLOVID for me and on Sunday I was still having symptoms and Monday I was feeling better. I tested again on Tuesday and I was negative.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Electromyogram, Muscle twitching
Clinical narrative: constant muscle twitching,
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abscess, Breast cellulitis, COVID-19, Chemotherapy, SARS-CoV-2 test positive
Clinical narrative: Patient up to date on COVID vaccinations who admitted with cellultis and found incidentally positive for COVID.  Provider note:  "44 year old female with triple-negative metaplastic carcinoma of the left breast with a biopsy-proven metastasis to her axillary lymph nodes and with local ulcerations/invasion of her skin.  She completed neoadjuvant chemotherapy 5 weeks ago.  She was scheduled for modified radical mastectomy on 8/24/22, but now presents with cellulitis of her left breast due to a seroma vs abscess in the left pectoralis musculature.  Also incidentally found to be COVID +."
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Seroma, Ulcer
Clinical narrative: Patient up to date on COVID vaccinations who admitted with cellultis and found incidentally positive for COVID.  Provider note:  "44 year old female with triple-negative metaplastic carcinoma of the left breast with a biopsy-proven metastasis to her axillary lymph nodes and with local ulcerations/invasion of her skin.  She completed neoadjuvant chemotherapy 5 weeks ago.  She was scheduled for modified radical mastectomy on 8/24/22, but now presents with cellulitis of her left breast due to a seroma vs abscess in the left pectoralis musculature.  Also incidentally found to be COVID +."
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Blood lactic acid increased, COVID-19, Cardiac telemetry abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Condition aggravated, Cough, Decreased appetite, Electrocardiogram abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Full blood count normal, Hypotension, Hypoxia, Laboratory test
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Metabolic function test, Metabolic function test normal, Myalgia, Nasal congestion
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Productive cough, Pyrexia, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep study, Tachycardia, Tachypnoea, Ventricular extrasystoles
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 8/25/2022 Discharge Date: 8/28/2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is an 87 y.o. male with h/o paroxysmal A-Fib/Flutter (on chronic Eliquis), essential HTN, NHL and recent diagnosis of COVID-19 infection via home test, who presented on 8/25 with c/o 2-day h/o sore throat, myalgias, and fatigue.  More recently, he has developed an accompanying cough and sinus/nasal congestion.  Cough has been increasingly productive.  He has measured intermittent fevers at home.  Family sought advice from his PCP, who referred them to the ER for additional evaluation.   In the ER, he was afebrile, borderline hypotensive, tachycardic, and tachypneic, hypoxic to 89% on baseline room air and maintained a SpO2 in the low to mid 90's on 2-3L via NC.  His initial labs were mostly unrevealing, with unremarkable CMP and CBC, and with only mild lactate elevation to 2.2.  CXR was limited but showed no clear intrathoracic processes.   EKG initially showed a wide complex tachycardia but he converted spontaneously into a sinus pattern with premature SV complexes. He remained comfortable and chest pain-free.  He was maintaining stable BP and HR's consistently in the 80-90's at rest and with ambulation to use the restroom.       While in the ER, he was given 1L of IV NS, a dose of IV labetalol, and started on dexamethasone. He was admitted with acute respiratory failure with hypoxia related to covid-19 for supportive care and monitoring.   The patient was weaned to room air on arrival to the inpatient floor on 8/26. He was placed on oxygen during the night into 8/27. He was observed for one more night and an overnight sleep study was completed as well as a walking sat study; he did not need supplemental oxygen. His Covid symptoms were minimal, an occasional cough, and fatigue. His appetite improved and intake was adequate.    He had three episodes of short duration wide complex tachycardia observed on telemetry while inpatient, he was asymptomatic. His metoprolol was increased from 25 to 50 mg, and no further tachycardia was noted. He will be discharged with a 14-day CV patch and recommended follow up with cardiology.   He was discharged home in stable condition, prescriptions sent to his pharmacy for tessalon and metoprolol XL 50 mg. Follow up appointment to be made by patient with PCP and Dr. from cardiology.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Heart rate increased
Clinical narrative: Possible Myocarditis - In September of 2021, I rejoined my kickboxing class, which is something that I have been doing for 15 years.  Immediately following a particularly strenuous training session (heart at peak rate), my heart suddenly went into a rapid heart pattern, forcing me to immediately stop what I was doing and drop to the ground. I was startled  as I had never experienced anything like that in my life.  It happened again one week pater, but not as bad.  For the next few months I reduced my training so not to reach high intensity and did not have that experience again.  It has now been a year and I have not experienced any more symptoms and have had high intensity training, so it appears to have resolved itself.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Balance disorder, Chest pain, Dysphemia, Insomnia
Clinical narrative: Swelling in left arm with rash 1st dose was injected in lower part of arm heart palpitations, stuttering, shaking uncontrollably, migraine headaches, chest pains feeling off balance and terrible back pain can't sleep at night and so many doctor visits to heart doctor and family medicine doctor and endocrinology for them all to say it's long haul Covid but I didn't feel this way until after I got my vaccine. Now my family doctor has referred me to internal medicine doctor because the care I need is above her knowledge.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Migraine, Palpitations, Peripheral swelling, Post-acute COVID-19 syndrome, Rash
Clinical narrative: Swelling in left arm with rash 1st dose was injected in lower part of arm heart palpitations, stuttering, shaking uncontrollably, migraine headaches, chest pains feeling off balance and terrible back pain can't sleep at night and so many doctor visits to heart doctor and family medicine doctor and endocrinology for them all to say it's long haul Covid but I didn't feel this way until after I got my vaccine. Now my family doctor has referred me to internal medicine doctor because the care I need is above her knowledge.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Swelling in left arm with rash 1st dose was injected in lower part of arm heart palpitations, stuttering, shaking uncontrollably, migraine headaches, chest pains feeling off balance and terrible back pain can't sleep at night and so many doctor visits to heart doctor and family medicine doctor and endocrinology for them all to say it's long haul Covid but I didn't feel this way until after I got my vaccine. Now my family doctor has referred me to internal medicine doctor because the care I need is above her knowledge.